CDK1 Acts as a Prognostic Biomarker Associated with Immune Infiltration in Pan-Cancer, Especially in Gastrointestinal Tumors.
Jiemiao ShenXing GongSiyue TanYuxin ZhangRong XiaShuyu XuShaozhuo WangHaojie ZhouYinyue JiangTie ZhaoYi ZhangHua TangChao WangPublished in: Current medicinal chemistry (2024)
Taken together, our data demonstrated the roles of CDK1 in oncogenesis and metastasis in pan-cancer. Thus, CDK1 is a potential prognostic biomarker and a target for tumor immunotherapy.